Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Comment by
Biotech010
on Mar 17, 2021 8:51am
RE:Thoughts on the updates today?
It was a smart move to have Andrew on the call, the director of business development.The last question on the Q&A was good, DPX goes beyond Ovarian DLBCL etc so there is room for lots of partners.
...more
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Comment by
Jthom376
on Mar 17, 2021 8:48am
RE:Thoughts on the updates today?
Another quarter of waiting is my take... which translates to all of 2021. Didn't really have a lot... gave a drug a name no one will be able to say. Not bad... just similar to every other
...more
(17)
•••
alphaseeking001
X
View Profile
View Bullboard History
Post by
alphaseeking001
on Mar 17, 2021 7:21am
Thoughts on the updates today?
Thoughts ladies and gents? Seems positive to me but would appreciate all thoughts. Cheers
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Comment by
Jthom376
on Mar 11, 2021 6:21pm
RE:RE:IMV scientific report
Thanks Q - it was above me... appreciate the nreak down. I initially got fixated on the anti inflammatory remarks noted but struggled to understand any of it.
(258)
•••
qwerty22
X
View Profile
View Bullboard History
Comment by
qwerty22
on Mar 11, 2021 1:29pm
RE:IMV scientific report
It's really just science. Maybe describe it as pre-preclinical. The importance to me is in relation to the dlbcl/pd-l1 finding. What this paper talks about is the importance of immune
...more
(5)
•••
alexmed95
X
View Profile
View Bullboard History
Comment by
alexmed95
on Mar 10, 2021 5:12pm
RE:RE:RE:RE:AACR abstracts in one weeks time
Nice find! Damn Nature is the most prestigious scientific journal!
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Comment by
Jthom376
on Mar 10, 2021 4:51pm
RE:RE:RE:AACR abstracts in one weeks time
I've looked all over AACR and don't find IMV anywhere. Released at 4:30 today. Anyone else?
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Post by
Jthom376
on Mar 10, 2021 2:37pm
IMV scientific report
Anyone have any thoughts on this? Hadn't noticed it until today. https://www.nature.com/articles/s41598-021-82108-4
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Comment by
Jthom376
on Mar 09, 2021 4:38pm
RE:RE:RE:Best takeaway
That would be a surprising development but his hopes my not be any better than my hopes... except mine cost me a lot! Would be nice! Especially combined with solid oncology.
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Comment by
Biotech010
on Mar 09, 2021 3:32pm
RE:RE:Best takeaway
they hope to start the Phase 1-2 of the COVID vaccine before the end of this quarter. Listen to the webcast at 25 minutes https://journey.ct.events/view/09b83699-20d3-4dc7-87a2-4a24596f4215
(258)
•••
qwerty22
X
View Profile
View Bullboard History
Comment by
qwerty22
on Mar 09, 2021 3:10pm
RE:Best takeaway
That seems to be the USP they are pushing from the Ov trial so good to see that extend.
(1)
•••
cribbons
X
View Profile
View Bullboard History
Post by
cribbons
on Mar 09, 2021 9:56am
Best takeaway
Multiple years of duration for the vaccine!
(2)
•••
Breakthorough
X
View Profile
View Bullboard History
Comment by
Breakthorough
on Mar 09, 2021 9:31am
RE:RE:March21 corp pres-
The important thing is that the three announcements dued to Q1 (DLBCL Trial design, ovarian biomarker, B. Trial interim data) are still announced for Q1 (see p. 28), meaning: during the three weeks
...more
(5)
•••
alexmed95
X
View Profile
View Bullboard History
Comment by
alexmed95
on Mar 09, 2021 9:25am
RE:March21 corp pres-
Won't lie, not so much good news for a long time...
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Mar 09, 2021 9:04am
March21 corp pres-
barely 3 changes fr Jan21: 1)monol OV- median duration of response now>12months, 2)dropped institutional invstr page, 3)WellsFargo analyst out.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income